Results of the randomized, placebo-controlled phase I/IIB trial of CV9104, an mRNA based cancer immunotherapy, in patients with metastatic castration-resistant prostate cancer (mCRPC)

Authors
Publication date
1 January 2017
Publisher
OXFORD UNIV PRESS

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Kölner UniversitätsPublikationsServer

    redirect
    oaioai:USBKOELN.ub.uni-koeln.de:2...
    Last time updated on 04/11/2020

    Kölner UniversitätsPublikationsServer

    redirect
    oaioai:USBKOELN.ub.uni-koeln.de:2...
    Last time updated on 05/02/2021

    Kölner UniversitätsPublikationsServer

    redirect
    oaioai:USBKOELN.ub.uni-koeln.de:2...
    Last time updated on 06/02/2021